Vaccines have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) morbidity and mortality, yet emerging variants challenge their effectiveness. The prevailing approach to updating ...
Interview with Dr. Garth Rapeport on the development and implementation of a SARS-CoV-2 human challenge research program. 11m 18s Download Human challenge studies (also called controlled human ...